share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Feb 21 23:55
Summary by Futu AI
Vertex Pharmaceuticals Inc. officer, Atkinson Edward Morrow III, is set to sell 1,201 shares of common stock on 02/21/2024, with an aggregate market value of $506,545.77. The shares were acquired on 02/20/2024 as performance shares, a form of compensation from the issuer. This transaction follows a recent history of sales by Morrow over the past three months, totaling 1,714 shares for gross proceeds of approximately $720,731.91.
Vertex Pharmaceuticals Inc. officer, Atkinson Edward Morrow III, is set to sell 1,201 shares of common stock on 02/21/2024, with an aggregate market value of $506,545.77. The shares were acquired on 02/20/2024 as performance shares, a form of compensation from the issuer. This transaction follows a recent history of sales by Morrow over the past three months, totaling 1,714 shares for gross proceeds of approximately $720,731.91.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.